Synthelabo

Sanofi-synthelabo

Daniele De Peretti

Pascal George

Mireille Sevrin

David Machnik

Philippe Michel Manoury

Benoit Marabout

Jean-Pierre Merly

Arlette Tixidre

Michel Peynot

Jocelyne Roy

John Allen

Jean Francedillaois Gibert

Guy Jaurand

8-azabicyclo&lsqb;3.2.1&rsqb; octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors

1-�2-(2,3-Dihydro-1H-inden-1-yl)ethyl!-4-(naphthalen-1-yl) piperazine,

Imidazo[1,2-a]pyridine derivatives of the general formula (I) ##STR1## wherein Y.sub.1 represents hydrogen, halogen or (C.sub.1-4) alkyl, Y.sub.2 represents --SR in which R is hydrogen, (C.sub.1-4) alkyl or (4-alkoxyphenyl)methyl or hydroxy or (C.sub.1-4) alkoxy, X represents hydrogen, halogen, (C.sub.1-4) alkoxy, (C.sub.1-4) alkyl, --CF.sub.3, --CH.sub.3 S, --NO.sub.2 or --NH.sub.2, and R.sub.1 and R2, which may be the same or different, represent hydrogen or (C.sub.1-4) alkyl have useful therapeutic properties.

Imidazopyridine derivatives and compositions containing them

A compound which is a 1-acylaminomethylimidazo[1,2-a]quinoline of formula (I) ##STR1## in which A and B both denote hydrogen or together denote a direct carbon-carbon bond,

1-(acylaminomethyl)imidazo(1,2-A)quinoline derivatives, their

Growing community of inventors

Antony, France

Daniele De Peretti